Messi Biology points out that within the vast chain of chemical pharmaceuticals, there is a white powder that does not appear directly on the final pill, yet plays a pivotal role in the birth of active pharmaceutical ingredients (APIs) and intermediates—that is magnesium hydroxide [Mg(OH)₂]. Armed with its unique combination of weak alkalinity, low solubility, and high safety, it is moving from behind the scenes to center stage in green pharmaceutics.
Magnesium hydroxide is a white amorphous powder. With a low solubility in water at 20°C and a saturated aqueous solution pH of around 10.3, it is a typical weak base. Its metabolic products are non-toxic, possess good biocompatibility, and do not generate carbon dioxide. These characteristics make it one of the few inorganic compounds included in pharmacopoeias worldwide that requires a purity level exceeding 99% for pharmaceutical grades. Its application scenarios are as follows:
pH Buffering and Acid Neutralization Agent: In intermediate synthesis and formulation preparation, reaction systems often “fall out of balance” due to the accumulation of acidic by-products. Due to its low solubility product, magnesium hydroxide releases OH⁻ ions at a gentle and sustained pace. Like a “quiet, nourishing rain,” it stabilizes the pH within the target range, prevents active ingredients from degrading due to acid-base fluctuations, and extends the shelf life of pharmaceuticals.
Mild Alkaline Reagent for Drug Synthesis: Taking the synthesis of the broad-spectrum antibacterial drug moxifloxacin as an example, its process needs to proceed under a specific alkaline environment. If strong bases such as sodium hydroxide are used, the reaction becomes violent, easily destroying sensitive chemical bonds and generating a large number of impurities. Magnesium hydroxide, however, drives the reaction forward in a “controlled-release” manner, significantly improving selectivity and yield while ensuring higher purity of the finished product.
Precipitating Agent and Impurity Purification Assistant: In complex organic synthesis, magnesium hydroxide can react with acidic impurities or heavy metal ions to form magnesium salt precipitates. These can be “packaged and removed” from the system through simple filtration, completing neutralization and purification in a single step and reducing subsequent ion exchange or resin treatment procedures.
Functional Excipients in Formulations: It simultaneously serves multiple roles as a filler, disintegrant, stabilizer, and carrier—improving the flowability of medicinal powders, aiding in tablet compaction, adsorbing unstable components to delay degradation, and maintaining the acid-base balance of the system in sustained-release preparations and medical buffers.
On the market front, the global magnesium hydroxide market size is projected to grow from $770 million in 2026 to $1.32 billion by 2034, registering a compound annual growth rate (CAGR) of approximately 7.0%. Demand for high-end pharmaceutical and food-grade products is expanding steadily. The focus of industry competition is shifting from production capacity scale to differentiated competition in high-purity and nano-grade products. From “threading the needle” at the molecular level to “escorting” the formulation stage, magnesium hydroxide interprets the wisdom of “combining firmness with gentleness” in modern pharmaceutical processes in a nearly understated manner. With the continuous upgrading of green pharmaceutical and high-end excipient standards, this “gentle chemist” still holds vast potential worth anticipating.